To further correlate the frequency of NKT cells with the downregulation of CD1d on CLL cells in the TCL1 mouse model over time, we stained blood samples from several mice at pre-leukemic and leukemic stage and monitored NKT cell levels and CD1d expression. This evidence concerns the gene CD1D and B-cell chronic lymphocytic leukemia.